Scientific conference spotlights PYC's work on blindness disease treatment
PYC Therapeutics Ltd will have data from its ongoing trial into a drug candidate to treat Retinitis Pigmentosa type 11 presented in Singapore
Corporate Spotlight
Not Yet Available
Are you a Company Director ?
Put your Investment Case to Hotcopper's 700K monthly unique visitors.
Announcements
Filter Results
FIG | Top 20 shareholders | 29/11/16 | ||
FIG | Distribution schedule | 29/11/16 | ||
FIG | Pre-quotation disclosure | 29/11/16 | ||
FIG | Constitution | 29/11/16 | ||
FIG | Appendix 1A and Information Form and Checklist | 29/11/16 | ||
FIG | Prospectus | 29/11/16 | ||
FIG | ASX Market Release - Pre-quotation disclosure | 29/11/16 | ||
FIG | ASX Market Release - Admission | PRICE SENSITIVE | 29/11/16 | |
FIG Top 20 shareholders | |||
29/11/16 | |||
FIG Distribution schedule | |||
29/11/16 | |||
FIG Pre-quotation disclosure | |||
29/11/16 | |||
FIG Constitution | |||
29/11/16 | |||
FIG Appendix 1A and Information Form and Checklist | |||
29/11/16 | |||
FIG Prospectus | |||
29/11/16 | |||
FIG ASX Market Release - Pre-quotation disclosure | |||
29/11/16 | |||
FIG ASX Market Release - Admission | |||
29/11/16 | PRICE SENSITIVE | ||